REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673,165 | -17.7% | 40,897 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $817,531 | +105660.8% | 40,897 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $773 | +15360.0% | 40,897 | +17303.0% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 235 | -56.1% | 0.00% | – |
| Q3 2022 | $14,000 | -41.7% | 535 | -45.7% | 0.00% | – |
| Q2 2022 | $24,000 | 0.0% | 985 | +34.0% | 0.00% | – |
| Q1 2022 | $24,000 | 0.0% | 735 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -20.0% | 735 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | +7.1% | 735 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | +12.0% | 735 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +13.6% | 735 | +47.0% | 0.00% | – |
| Q4 2020 | $22,000 | +69.2% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | +116.7% | 500 | +400.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |